Abbvie Inc
NYSE:ABBV
Abbvie Inc
PP&E Net
Abbvie Inc
PP&E Net Peer Comparison
Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors
Company | PP&E Net | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abbvie Inc
NYSE:ABBV
|
PP&E Net
$5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
PP&E Net
$5.3B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
16%
|
|
Amgen Inc
NASDAQ:AMGN
|
PP&E Net
$5.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
1%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
PP&E Net
$1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
PP&E Net
$4.1B
|
CAGR 3-Years
9%
|
CAGR 5-Years
10%
|
CAGR 10-Years
23%
|
|
Seagen Inc
NASDAQ:SGEN
|
PP&E Net
$487.7m
|
CAGR 3-Years
24%
|
CAGR 5-Years
37%
|
CAGR 10-Years
29%
|
See Also
What is Abbvie Inc's PP&E Net?
PP&E Net
5B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's PP&E Net amounts to 5B USD.
What is Abbvie Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
8%
Over the last year, the PP&E Net growth was 1%. The average annual PP&E Net growth rates for Abbvie Inc have been -2% over the past three years , 12% over the past five years , and 8% over the past ten years .